High degree of agreement |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
Non-modifiable risk factors |
Personal and family medical history |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
Modifiable risk factors |
Blood pressure/pulse |
√ |
|
√ |
√ |
√ |
√ |
√ |
√ |
Body Mass Index |
√ |
|
√ |
√ |
√ |
√ |
√ |
√ |
Glucose levels |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
Lipid levels |
√ |
|
√ |
√ |
√ |
√ |
√ |
√ |
Weight |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
|
Medium degree of agreement |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
Modifiable risk factors |
Drug use |
√ |
√ |
√ |
|
|
√ |
√ |
√ |
Electrocardiogram |
|
√ |
√ |
|
|
√ |
√ |
√ |
Extrapyramidal symptoms, dyskinesia or other side effects |
|
√ |
√ |
|
√ |
√ |
√ |
√ |
Height |
√ |
|
√ |
|
|
√ |
√ |
√ |
Lifestyle (diet, exercise, etc.) |
√ |
|
√ |
√ |
|
√ |
√ |
|
Sexual dysfunction |
|
|
√ |
√ |
|
|
√ |
√ |
Waist circumference |
√ |
|
√ |
√ |
√ |
√ |
|
√ |
|
Low degree of agreement |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
Modifiable risk factors |
Blood count |
|
√ |
|
|
|
|
√ |
√ |
Hepatic function |
|
|
√ |
|
|
√ |
|
|
Magnetic resonance imaging or tomography |
|
|
|
|
|
|
√ |
|
Mammography/prostate specific antigen |
|
|
|
|
|
|
√ |
|
Menstruation |
|
|
|
√ |
|
|
|
|
Neurological and motor disorder |
|
|
|
|
|
|
√ |
|
Physical examination (dental health, ocular health, etc.) |
|
√ |
|
|
|
|
√ |
√ |
Pregnancy test |
|
|
|
|
|
|
√ |
|
Prolactin |
|
|
√ |
√ |
|
|
|
√ |
Renal function |
|
|
|
|
|
√ |
|
√ |
Sedation |
|
|
√ |
|
|
|
|
|
Serology |
|
|
|
|
|
|
√ |
√ |
Sexual risk behavior |
|
|
|
|
|
|
√ |
√ |
Thyroid function |
|
|
√ |
|
|
√ |
|
√ |
Urine/biochemistry |
|
|
√ |
|
|
|
√ |
|
1 = Barnett; 2 = British Association of Psychopharmacology; 3 = British Association
of Psychopharmacology; 4 = Heald; 5 = Ministry of Health Clinical Practice Guidelines
Workgroup on Schizophrenia; 6 = NICE; 7 = Working Group of the Clinical
Practice Guideline for Schizophrenia and Incipient Psychosis Disorder; 8 = Working
Group on the Physical Health of Patients with Schizophrenia